• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > Research > Technology Transfer

Technology Transfer

tech_trans_header

The LMB is internationally renowned for world class research, innovation and technology transfer. Where possible, scientists are encouraged to exploit and disseminate their discoveries – helping to improve quality of life and the economic competitiveness of the UK and pioneering new research methods.

The LMB’s focus on curiosity-driven fundamental research means that the ‘development gap’ between LMB discoveries and bringing new treatments and/or diagnostics to the market is wide.

However, there have been some notable successes, including the LMB’s development of humanised monoclonal and synthetic antibodies – which now make up a third of all new drug treatments for a variety of diseases, including cancer, arthritis and asthma.

LMB researchers are supported by LifeArc (originally launched as MRC Technology in the 1990s) in advancing novel discoveries to accelerate impact and benefit health by providing funding to support translation, assisting in the establishment of collaborative agreements with industrial partners, advising on commercial potential, protecting intellectual property and catalysing commercialisation via licensing to industry or spin-out company creation.

When intelligently exploited, fundamental research pays handsome dividends for both human health and UK industry. For example, the licensing of the LMB’s work on human antibodies to local start-up company Cambridge Antibody Technology led to the development of Humira® a key drug in the treatment of rheumatoid arthritis.

Intellectual property created at the LMB has also benefited the MRC through income generation. Although antibody income is now decreasing as key patents expire, to date an income of over £700 million from royalties, share sales and licensing of a range of intellectual property has been generated.

For more information about the work done by LifeArc to accelerate the impact of research done by LMB scientists, and those at other MRC establishments, please see the LifeArc “Expanding horizons” brochure.

LifeArc MRC Brochure

1 file(s) 3.00 MB
Download

For any query related to the content of these pages and Technology Transfer in general please contact the LMB Research Office: 

Primary Sidebar

Research

  • Goals and Research Focus
  • Cell Biology
  • Neurobiology
    • Initiative with the Department of Clinical Neurosciences
  • Protein and Nucleic Acid Chemistry
    • Centre for Chemical and Synthetic Biology
  • Structural Studies
  • Technology Transfer
    • History Of Technology Transfer
    • Neonatal Mouse Anaesthetisation Mould Request Form
    • Chinlab Software
    • Examples of Recent Technology Transfer Initiatives
      • Bicycle Therapeutics
      • Mesolens Microscopy
      • Gold EM Support Grids
      • In Vitro Compartmentalization (IVC)
      • CombiPuck
      • SiR (Self-inactivating Rabies virus)
      • MORPHEUS III
      • Trim-Away
      • PepGen
      • Raphin 1
      • Transgenic mice expressing human P301S tau protein (continued success since 2002)
      • Therapeutic Antibodies
  • Scientific Facilities & Support Services
    • Biological Services Group
    • Biophysics
    • Crystallisation and X-ray
    • Electron Microscopy
    • Flow Cytometry
    • Light Microscopy
    • Mass Spectrometry
    • Nanobody
    • NMR
    • Scientific Computing
    • Workshops
    • Support Services
  • Locally Developed Software
    • Image Processing Software
  • Scientific Training
    • Electron Microscopy
    • Biophysics Lectures
    • Macromolecular Crystallisation
    • Crystallography Course 2013
    • Statistics Course 2014
    • RNA-seq course 2020
  • Published Research
  • Molecular Immunity Unit
  • Animal Research
    • Why is animal research needed?
    • Alternatives to using Animals in Research
    • Welfare and ethics
    • LMB Research Involving Animals
    • LMB Animal Research Facts and Figures
    • Biological Services Group
    • Concordat on Openness in Animal Research
    • Useful Links
  • Blue Sky Collaboration
  • LMB COVID-19 response

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2023 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us